Valuation dashboard for Apimeds Pharmaceuticals US, Inc (APUS) with P/E N/A, P/B 0.02, EV/EBITDA -0.33 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $1.60, APUS has negative trailing earnings (P/E not meaningful) and an ROE of -58.98%. Market capitalisation stands at $2M.
Balance sheet quality for APUS: current ratio of 1.3. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.02 |
| EV / EBITDA | -0.33 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-6.43 |
| vs Current Price | -502.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| APUS | Apimeds Pharmaceuticals US, Inc | $2M | 0.02 | -59.0% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $1.60 |
| Market Cap | $2M |
| Exchange | AMEX |
| Country | US |
Profitability
| Return on Equity | -58.98% |
| Return on Invested Capital | -15.89% |
| Return on Assets | -45.58% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: ANTX · IGC · MIRA · MLSS · MYO · NXTC · POCI
Explore sector: Healthcare · Biotechnology
More sections of APUS: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks